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In their interesting study on canine mam-
mary tumors published in the Brazilian Jour-
nal of Medical and Biological Research,
Dutra et al. (1) evaluated the influence of c-
erbB-2 expression and nuclear polymor-
phism on survival using a semiquantitative
scoring system. Survival was calculated us-
ing the Spearman rank correlation test. They
obtained a regression coefficient of r = 0.441
for c-erbB-2 expression and of r = -0.295 for
nuclear polymorphism, with P > 0.05 in
both cases. Therefore, the authors concluded
that neither c-erbB-2 nor nuclear polymor-
phism could be considered to be prognostic
factors.
We would like to discuss some of the
methodological aspects of the study.
1. In survival studies some individuals
will still be alive at the end. Others may have
been lost to follow-up some time earlier and
thus survival times will be unknown for a
subset of the study group. There is a consen-
sus that these so-called “censored” cases
must be included in the analysis. Most sur-
vival analyses use Kaplan-Meier plots, log
rank tests or the Cox proportional hazard
regression (2). A Spearman rank order cor-
relation test, as carried out by Dutra et al.
(1), can only be used if all the animals under
observation die (2).
2. Both variables examined, c-erbB-2
expression and nuclear pleomorphism, were
evaluated using a semiquantitative scoring
system. Categorizing variables that are meas-
ured on a continuum is a frequently used
procedure in medicine, especially in surgical
pathology. By looking, for instance, at re-
cently published issues of this Journal, we
can see considerable variation in the scoring
systems applied in histopathology, not only
between different groups but also within the
same laboratory (1,3-6).
It is well known that categorization may
be useful for clinical decision-making, treat-
ment recommendations, determining study
eligibility, or for illustration purposes (7),
but we should be well aware that this proce-
dure is dangerous for several reasons.
When the probability of an event associ-
ated with a quantitative prognostic factor
varies monotonously, the selection of a cut-
off point is always arbitrary. This may create
scientifically unrealistic models because this
procedure discards potentially important in-
formation since all values between the cut-
off levels have an equal effect on the model.
Therefore, categorization considerably low-
ers the statistical test-power and can be seen
as an introduction of measurement errors (8-
14).
This can be easily illustrated with a simple
experiment. In Table 1 we simulated a pos-
sible situation similar to that of the study of
Dutra et al. (1): let us assume that 10 of 17
dogs with neoplasia died. The percentages of
c-erbB-2-positive cells in the tumors had
Quantification in histopathology - some pitfalls
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been counted as percentage values and then
were transformed by the HercepTest scoring
system, assuming that none of the cells
showed faint staining. When analyzing the
scores by the Kaplan-Meier survival plot
followed by the log rank test we cannot show
any significant influence of c-erbB-2 on over-
all survival (P = 0.131; SPSS 10.0 software).
Similarly, c-erbB-2 scores analyzed by Cox
regression were not significant either when
simply entering the categories or when using
the quotient calculated between observed
and expected events in the log rank test of the
Kaplan-Meier model, as suggested recently,
thus considering the natural order between
the categories (15). But when we include the
continuous percentage values in the Cox
proportional hazard model, we discover a
significant influence of c-erbB-2 expression
on overall survival (P = 0.017, B = 0.0834;
SPSS 10.0).
Thus, our example shows that even in
studies with small sample size it is possible
to detect prognostic factors with statistical
significance when using continuous data.
Choosing the cut-off points of a continu-
ously measured variable is in most cases
arbitrary or opportunistic (16). The so-called
minimum P-value approach involves mul-
tiple testing which inflates the type I error
rates and is therefore not recommended (8).
Variations in the choice of cut-off points
between different studies provoke a bias
called the ‘Will Rogers phenomenon’, which
describes an apparent improvement of prog-
nosis in subgroups due to classification or
categorization changes, but which is not ac-
companied by an overall improvement of
survival (11). Therefore, the results of stud-
ies using different cut-off points may not be
comparable at all. In this context the use of a
previously defined classification system, in
our case the HercepTest scoring system, is
certainly of advantage. But this classifica-
tion system was created in order to identify
patients who would probably benefit from a
specific therapy. Yet this is not the topic of
the present study on prognostic variables
and therefore possible relevant cut-off points
may be completely different for this pur-
pose. In summary, the accuracy and reliabil-
ity of a study may be compromised by cat-
egorization of continuous data or qualitative
interpretations. Categorization of a variable
which can be continuously measured should
be done only exceptionally. For instance,
when precise measurement is difficult, the
distribution of the variable is highly skewed
or its relation with another variable is non-
linear (8,10,17).
Therefore, we suggest that immunohisto-
chemical expression should be quantified as
done for the MIB-1 antibody, i.e., by count-
ing the percentage of antibody-stained cells.
One may argue that this method will not take
into consideration differences in staining in-
tensity between the cells. In this case the
immunohistochemical reaction product may
be easily quantified with interactive soft-
ware applied to digitized images. Nuclear
pleomorphism can also be easily and pre-
cisely quantified using texture analysis of
digitized images (18-21). Therefore, we be-
lieve that a re-evaluation of the material
Table 1. Simulation of survival data in order to
show the effect of categorization.
Final event Follow-up Percentage HercepTest
expired = 1 (weeks) of positive cells score
1 45 8 0
1 19 3 0
1 75 9 0
0 35 6 0
1 74 9 0
0 55 9 0
1 25 4 0
0 65 4 0
1 50 8 0
0 70 3 0
1 40 9 0
0 18 10 2
1 45 10 2
0 50 10 2
1 18 45 3
1 25 35 3
0 30 13 3
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presented in the study by Dutra et al. (1)
using continuous data and a survival analy-
sis including censored observations might
reveal the prognostic relevance of the vari-
ables under study.
